Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis

Experimental Neurology

Volumn 262, Issue Part B, 2014, Pages 121-126

  Ravits, John ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ALS; Continuous phenotypic variation; Discontinuous genetic traits; FTD; Motor neuron degeneration; Motor neuron disease; PLS; PMA; Prion like propagation; Propagation

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; DISEASE ACTIVITY; DISEASE COURSE; FAMILIAL DISEASE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; MOTONEURON; MOTOR DYSFUNCTION; MOTOR SYSTEM; NERVE DEGENERATION; NEUROANATOMY; NEUROPATHOLOGY; PHENOTYPIC VARIATION; REVIEW; GENETICS; NERVE TRACT; PATHOLOGY; PHENOTYPE; STATISTICS;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; MOTOR NEURONS; NEURAL PATHWAYS; NEUROANATOMY; PHENOTYPE; STOCHASTIC PROCESSES;

EID: 84908154846     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.07.021     Document Type: Review

References (62)

1. Abmayr S., Weydt P. Skeletal muscle in amyotrophic lateral sclerosis: emerging concepts and therapeutic implications. Phys. Med. Rehabil. Clin. N. Am. 2005, 16(4):1091-1097.
2. Aguzzi A., Rajendran L. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 2009, 64(6):783-790.
3. Andres P.L., Thibodeau L.M., Finison L.J., Munsat T.L. Quantitative assessment of neuromuscular deficit in ALS. Neurol. Clin. 1987, 5(1):125-141.
4. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006, 351(3):602-611.
5. Braak H., Ludolph A., Thal D.R., Del Tredici K. Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord. Acta Neuropathol. 2010, 120(1):67-74.
6. Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., Del Tredici K. Amyotrophic lateral sclerosis-a model of corticofugal axonal spread. Nat. Rev. Neurol. 2013, 9(12):708-714.
7. Brettschneider J., Del Tredici K., Toledo J.B., Robinson J.L., Irwin D.J., Grossman M., Trojanowski J.Q. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013, 74(1):20-38.
8. Brettschneider J., Arai K., Del Tredici K., Toledo J.B., Robinson J.L., Lee E.B., Trojanowski J.Q. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 2014.
9. Brooks B.R. The role of axonal transport in neurodegenerative disease spread: a meta-analysis of experimental and clinical poliomyelitis compares with amyotrophic lateral sclerosis. Can. J. Neurol. Sci. 1991, 18(3 Suppl.):435-438.
10. Buratti E., Baralle F.E. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front. Biosci. 2008, 13:867-878.
11. Chio A., Calvo A., Moglia C., Mazzini L., Mora G., Group, P.s Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J. Neurol. Neurosurg. Psychiatry 2011, 82(7):740-746.
12. Chou S.M., Norris F.H. Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons. Muscle Nerve 1993, 16(8):864-869.
13. Chow T.W. What are the different initial presentations of frontotemporal dementia?. J. Mol. Neurosci. 2011, 45(3):710-712.
14. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., Cleveland D.W. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003, 302(5642):113-117.
15. Cortes C.J., Ling S.C., Guo L.T., Hung G., Tsunemi T., Ly L., La Spada A.R. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 2014, 82(2):295-307.
16. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72(2):245-256.
17. Eisen A., Kim S., Pant B. Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron?. Muscle Nerve 1992, 15(2):219-224.
18. Finsterer J., Burgunder J.M. Recent progress in the genetics of motor neuron disease. Eur. J. Med. Genet. 2014, 57(2-3):103-112.
19. Fujimura-Kiyono C., Kimura F., Ishida S., Nakajima H., Hosokawa T., Sugino M., Hanafusa T. Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 2011, 82(11):1244-1249.
20. Furukawa Y., Kaneko K., Watanabe S., Yamanaka K., Nukina N. A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J. Biol. Chem. 2011, 286(21):18664-18672.
21. Ganesalingam J., Stahl D., Wijesekera L., Galtrey C., Shaw C.E., Leigh P.N., Al-Chalabi A. Latent cluster analysis of ALS phenotypes identifies prognostically differing groups. PLoS One 2009, 4(9):e7107.
22. Gargiulo-Monachelli G.M., Janota F., Bettini M., Shoesmith C.L., Strong M.J., Sica R.E. Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis. Eur. J. Neurol. 2012, 19(6):834-841.
23. Geser F., Stein B., Partain M., Elman L.B., McCluskey L.F., Xie S.X., Trojanowski J.Q. Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy. Acta Neuropathol. 2011, 121(4):509-517.
24. Grad L.I., Yerbury J.J., Turner B.J., Guest W.C., Pokrishevsky E., O'Neill M.A., Cashman N.R. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(9):3620-3625.
25. Ince P.G., Evans J., Knopp M., Forster G., Hamdalla H.H., Wharton S.B., Shaw P.J. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003, 60(8):1252-1258.
26. Kanouchi T., Ohkubo T., Yokota T. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?. J. Neurol. Neurosurg. Psychiatry 2012, 83(7):739-745.
27. Kfoury N., Holmes B.B., Jiang H., Holtzman D.M., Diamond M.I. Trans-cellular propagation of Tau aggregation by fibrillar species. J. Biol. Chem. 2012, 287(23):19440-19451.
28. Kiernan J.A., Hudson A.J. Frontal lobe atrophy in motor neuron diseases. Brain 1994, 117(Pt 4):747-757.
29. Kobayashi Z., Tsuchiya K., Arai T., Yokota O., Yoshida M., Shimomura Y., Mizusawa H. Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss. J. Neurol. Sci. 2010, 298(1-2):70-77.
30. Korner S., Kollewe K., Fahlbusch M., Zapf A., Dengler R., Krampfl K., Petri S. Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis. Muscle Nerve 2011, 43(5):636-642.
31. Kosaka T., Fu Y.J., Shiga A., Ishidaira H., Tan C.F., Tani T., Takahashi H. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration-immunohistochemical and biochemical analyses of TDP-43. Neuropathology 2012, 32(4):373-384.
32. Lagier-Tourenne C., Cleveland D.W. Rethinking ALS: the FUS about TDP-43. Cell 2009, 136(6):1001-1004.
33. Lemon R.N. Descending pathways in motor control. Annu. Rev. Neurosci. 2008, 31:195-218.
34. Ling S.C., Polymenidou M., Cleveland D.W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 2013, 79(3):416-438.
35. Lomen-Hoerth C., Anderson T., Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002, 59(7):1077-1079.
36. Lomen-Hoerth C., Murphy J., Langmore S., Kramer J.H., Olney R.K., Miller B. Are amyotrophic lateral sclerosis patients cognitively normal?. Neurology 2003, 60(7):1094-1097.
37. Mori F., Tanji K., Zhang H.X., Nishihira Y., Tan C.F., Takahashi H., Wakabayashi K. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 2008, 116(2):193-203.
38. Munch C., O'Brien J., Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(9):3548-3553.
39. Munsat T.L., Andres P.L., Finison L., Conlon T., Thibodeau L. The natural history of motoneuron loss in amyotrophic lateral sclerosis. Neurology 1988, 38(3):409-413.
40. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314(5796):130-133.
41. Nonaka T., Masuda-Suzukake M., Arai T., Hasegawa Y., Akatsu H., Obi T., Hasegawa M. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013, 4(1):124-134.
42. Pan X.D., Chen X.C. Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review. Transl. Neurodegener. 2013, 2(1):8.
43. Polymenidou M., Cleveland D.W. The seeds of neurodegeneration: prion-like spreading in ALS. Cell 2011, 147(3):498-508.
44. Ravits J.M., La Spada A.R. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 2009, 73(10):805-811.
45. Ravits J., Laurie P., Fan Y., Moore D.H. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology 2007, 68(19):1576-1582.
46. Ravits J., Paul P., Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 2007, 68(19):1571-1575.
47. Renton A.E., Majounie E., Waite A., Simon-Sanchez J., Rollinson S., Gibbs J.R., Traynor B.J. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72(2):257-268.
48. Renton A.E., Chio A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014, 17(1):17-23.
49. Sacino A.N., Brooks M., Thomas M.A., McKinney A.B., Lee S., Regenhardt R.W., Giasson B.I. Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 2014.
50. Sanelli T., Xiao S., Horne P., Bilbao J., Zinman L., Robertson J. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2007, 66(12):1147-1153.
51. Seeley W.W. Selective functional, regional, and neuronal vulnerability in frontotemporal dementia. Curr. Opin. Neurol. 2008, 21(6):701-707.
52. Seeley W.W., Crawford R.K., Zhou J., Miller B.L., Greicius M.D. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009, 62(1):42-52.
53. Sekiguchi T., Kanouchi T., Shibuya K., Noto Y., Yagi Y., Inaba A., Yokota T. Spreading of amyotrophic lateral sclerosis lesions-multifocal hits and local propagation?. J. Neurol. Neurosurg. Psychiatry 2014, 85(1):85-91.
54. Sieben A., Van Langenhove T., Engelborghs S., Martin J.J., Boon P., Cras P., Cruts M. The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol. 2012, 124(3):353-372.
55. Smith R.A., Bowser R., Ravits J. Sporadic ALS: a spinal fluid pathway disorder?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2013, 14(Supplement 2):1. (Abstract).
56. Strong M.J., Grace G.M., Orange J.B., Leeper H.A., Menon R.S., Aere C. A prospective study of cognitive impairment in ALS. Neurology 1999, 53(8):1665-1670.
57. Sumi H., Kato S., Mochimaru Y., Fujimura H., Etoh M., Sakoda S. Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2009, 68(1):37-47.
58. Turner M.R., Brockington A., Scaber J., Hollinger H., Marsden R., Shaw P.J., Talbot K. Pattern of spread and prognosis in lower limb-onset ALS. Amyotroph. Lateral Scler. 2010, 11(4):369-373.
59. Uchida A., Sasaguri H., Kimura N., Tajiri M., Ohkubo T., Ono F., Yokota T. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43. Brain 2012, 135(Pt 3):833-846.
60. Volpicelli-Daley L.A., Luk K.C., Patel T.P., Tanik S.A., Riddle D.M., Stieber A., Lee V.M. Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011, 72(1):57-71.
61. Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008, 11(3):251-253.
62. Zhou J., Gennatas E.D., Kramer J.H., Miller B.L., Seeley W.W. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron 2012, 73(6):1216-1227.